Skip to main content

Table 1 Patients were treated in four cohorts

From: Systemic and local immunity following adoptive transfer of NY-ESO-1 SPEAR T cells in synovial sarcoma

Cohort Antigen expression by IHC Lymphodepletion regimen
1 2+ or 3+ in ≥50% of tumor cells Flu 30 mg/m2/d × 4 + Cy 1800 mg/m2/d × 2
2 >  1+ in > 1% but < 2+ or 3+ in ≥50% of tumor cells Flu 30 mg/m2/d × 4 + Cy 1800 mg/m2/d × 2
3 2+ or 3+ in ≥50% of tumor cells Cy 1800 mg/m2/d × 2
4 2+ or 3+ in ≥50% of tumor cells Flu 30 mg/m2/d × 3 + Cy 600 mg/m2/d × 3